NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. ("Sable" or the "Company") (NYSE:SOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sable and certain of its officers and/or directors […]
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of WPP plc ("WPP" or the "Company") (NASDAQ:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether WPP and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ:MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Mereo and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE:EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ZEEKR Intelligent Technology Holding Limited ("Zeekr" or the "Company") (NYSE:ZK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zeekr and certain of its
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund ("the Fund" or the "Company") (NASDAQ:RMHIX; RMHVX; RMJAX). Such investors are advised to
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NYSE:VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE:BHVN) and certain officers. The class action, filed in the United States District Court for the District of Connecticut, and docketed under 25-cv-01120, is on
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Bancorp, Inc. ("Bancorp" or "the Company") (NASDAQ:TBBK). Investors who purchased Bancorp securities prior to January 25, 2024, and continue to hold to the present, are encouraged to obtain